ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2019/03/01 | 3,120 | 3,205 | 3,095 | 3,140 | +55 | +1.8% | 131,700 |
| 2019/02/28 | 3,300 | 3,300 | 3,080 | 3,085 | -160 | -4.9% | 194,900 |
| 2019/02/27 | 3,055 | 3,255 | 3,055 | 3,245 | +170 | +5.5% | 200,500 |
| 2019/02/26 | 3,175 | 3,225 | 3,050 | 3,075 | -85 | -2.7% | 182,300 |
| 2019/02/25 | 3,145 | 3,205 | 3,095 | 3,160 | +45 | +1.4% | 125,500 |
| 2019/02/22 | 3,225 | 3,245 | 3,100 | 3,115 | -140 | -4.3% | 175,100 |
| 2019/02/21 | 3,180 | 3,265 | 3,130 | 3,255 | +130 | +4.2% | 164,800 |
| 2019/02/20 | 3,210 | 3,275 | 3,120 | 3,125 | -65 | -2% | 195,000 |
| 2019/02/19 | 3,075 | 3,290 | 3,065 | 3,190 | +10 | +0.3% | 227,600 |
| 2019/02/18 | 3,290 | 3,300 | 3,130 | 3,180 | -85 | -2.6% | 251,800 |
| 2019/02/15 | 3,385 | 3,420 | 3,260 | 3,265 | +20 | +0.6% | 292,000 |
| 2019/02/14 | 3,480 | 3,620 | 3,240 | 3,245 | -435 | -11.8% | 432,500 |
| 2019/02/13 | 3,570 | 3,695 | 3,510 | 3,680 | +180 | +5.1% | 229,700 |
| 2019/02/12 | 3,325 | 3,520 | 3,310 | 3,500 | +230 | +7% | 155,000 |
| 2019/02/08 | 3,370 | 3,400 | 3,235 | 3,270 | -180 | -5.2% | 171,800 |
| 2019/02/07 | 3,590 | 3,610 | 3,405 | 3,450 | -80 | -2.3% | 164,700 |
| 2019/02/06 | 3,520 | 3,565 | 3,445 | 3,530 | +45 | +1.3% | 94,700 |
| 2019/02/05 | 3,340 | 3,580 | 3,340 | 3,485 | +175 | +5.3% | 267,400 |
| 2019/02/04 | 3,225 | 3,355 | 3,210 | 3,310 | +115 | +3.6% | 158,600 |
| 2019/02/01 | 3,180 | 3,205 | 3,110 | 3,195 | -20 | -0.6% | 126,500 |
| 2019/01/31 | 3,105 | 3,225 | 3,040 | 3,215 | +229 | +7.7% | 273,300 |
| 2019/01/30 | 3,055 | 3,060 | 2,920 | 2,986 | -194 | -6.1% | 429,600 |
| 2019/01/29 | 3,125 | 3,180 | 3,055 | 3,180 | +5 | +0.2% | 169,600 |
| 2019/01/28 | 3,340 | 3,340 | 3,170 | 3,175 | -135 | -4.1% | 137,200 |
| 2019/01/25 | 3,380 | 3,415 | 3,305 | 3,310 | -40 | -1.2% | 126,800 |
| 2019/01/24 | 3,310 | 3,360 | 3,270 | 3,350 | +30 | +0.9% | 84,400 |
| 2019/01/23 | 3,310 | 3,395 | 3,225 | 3,320 | -25 | -0.7% | 184,800 |
| 2019/01/22 | 3,525 | 3,580 | 3,330 | 3,345 | -125 | -3.6% | 195,500 |
| 2019/01/21 | 3,640 | 3,700 | 3,455 | 3,470 | -125 | -3.5% | 199,100 |
| 2019/01/18 | 3,575 | 3,640 | 3,530 | 3,595 | +80 | +2.3% | 164,900 |
| 2019/01/17 | 3,440 | 3,535 | 3,435 | 3,515 | +120 | +3.5% | 188,000 |
| 2019/01/16 | 3,435 | 3,490 | 3,370 | 3,395 | -15 | -0.4% | 152,900 |
| 2019/01/15 | 3,235 | 3,470 | 3,225 | 3,410 | +185 | +5.7% | 221,800 |
| 2019/01/11 | 3,300 | 3,330 | 3,215 | 3,225 | -50 | -1.5% | 114,600 |
| 2019/01/10 | 3,380 | 3,450 | 3,265 | 3,275 | -130 | -3.8% | 174,100 |
| 2019/01/09 | 3,435 | 3,465 | 3,340 | 3,405 | +5 | +0.1% | 200,700 |
| 2019/01/08 | 3,350 | 3,450 | 3,330 | 3,400 | +70 | +2.1% | 233,300 |
| 2019/01/07 | 3,355 | 3,375 | 3,250 | 3,330 | +115 | +3.6% | 239,400 |
| 2019/01/04 | 2,961 | 3,245 | 2,932 | 3,215 | +150 | +4.9% | 296,600 |
| 2018/12/28 | 3,055 | 3,155 | 3,025 | 3,065 | -55 | -1.8% | 206,400 |
| 2018/12/27 | 3,110 | 3,180 | 2,995 | 3,120 | +256 | +8.9% | 304,200 |
| 2018/12/26 | 2,934 | 2,970 | 2,768 | 2,864 | +96 | +3.5% | 288,300 |
| 2018/12/25 | 2,959 | 2,970 | 2,665 | 2,768 | -427 | -13.4% | 576,900 |
| 2018/12/21 | 3,240 | 3,295 | 3,100 | 3,195 | +25 | +0.8% | 265,200 |
| 2018/12/20 | 3,350 | 3,400 | 3,095 | 3,170 | -250 | -7.3% | 327,600 |
| 2018/12/19 | 3,445 | 3,525 | 3,265 | 3,420 | -15 | -0.4% | 200,400 |
| 2018/12/18 | 3,600 | 3,625 | 3,425 | 3,435 | -265 | -7.2% | 326,100 |
| 2018/12/17 | 3,825 | 3,880 | 3,685 | 3,700 | -165 | -4.3% | 137,600 |
| 2018/12/14 | 3,880 | 3,930 | 3,770 | 3,865 | +80 | +2.1% | 192,600 |
| 2018/12/13 | 3,800 | 3,865 | 3,735 | 3,785 | +15 | +0.4% | 145,800 |
1501～
1550
件表示中 / 3687件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 223,700円 | +21.7% | +999.9% | 0.00% | 9.32倍 | 3.08倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| ゼリア新薬 | 232,500円 | +14.2% | +41.0% | 1.98% | 11.39倍 | 1.16倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 持田薬 | 311,000円 | +3.0% | +27.5% | 2.57% | 19.69倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 杏林製薬 | 149,500円 | +8.8% | +99.9% | 3.48% | 9.54倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 225,100円 | +0.4% | -8.4% | 2.35% | 28.90倍 | 1.63倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
